Enrolling Now
Study Information

Large-scale Phase 3 clinical research focusing on primary cardiovascular prevention, evaluating long-term therapies that help prevent major adverse cardiac events like heart attacks or strokes in high-risk individuals.

Basic Eligibility: High-risk primary prevention patients or individuals with a documented clinical history of cardiovascular disease.

Apply to Participate

If you are interested in participating in this study, please complete the following preliminary qualification form.

We will follow-up with you after we have received your submission.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

General Information

Name*

Preferences

Areas of Interest
Email Opt-In*
SMS/Text Opt-In*